Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study
Yoshiki Hanaoka, Tsubasa Takizawa, Ryotaro Ishii, Daisuke Danno, Masayuki Hamakawa, Kaname Ueda, Yoshinori Tanizawa, Satoshi Osaga, Leo J Philip Tharappel, Chie Hashimoto · 2026
Read Calcitonin Gene-Related Peptide Monoclonal Antibody Utilization and Treatment Gaps in People with Migraine in Japan: Results from the OVERCOME (Japan) 2nd Study by Yoshiki Hanaoka, Tsubasa Takizawa, Ryotaro Ishii, Daisuke Danno, Masayuki Hamakawa, Kaname Ueda, Yoshinori Tanizawa, Satoshi Osaga, Leo J Philip Tharappel, Chie Hashimoto (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13570857.txt.
Description
Yoshiki Hanaoka and colleagues analyze, in a 2026 analysis of a nationwide Japanese survey, how widely newer migraine prevention antibodies targeting a pain-related peptide are actually used. Among 19,590 survey respondents with migraine, about fifteen hundred met national eligibility rules for these injections, and their treatment histories, attitudes, and barriers were compared.
Only seventy-eight eligible people were currently using the treatment and fifty-eight had stopped, leaving about ninety percent of eligible patients never treated. Statistical modeling searched for what separated treated from untreated patients. The gap between proven benefit and real uptake gives neurologists and policy makers a target: finding and offering treatment to eligible patients who remain on older, less effective prevention.
Catalog record
| CREATOR | Yoshiki Hanaoka, Tsubasa Takizawa, Ryotaro Ishii, Daisuke Danno, Masayuki Hamakawa, Kaname Ueda, Yoshinori Tanizawa, Satoshi Osaga, Leo J Philip Tharappel, Chie Hashimoto |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 69504 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |